In the latest quarter, 14 analysts provided ratings for Sarepta Therapeutics (NASDAQ:SRPT), showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 6 | 3 | 5 | 0 | 0 |
| Last 30D | 1 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 5 | 3 | 4 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $157.21, with a high estimate of $224.00 and a low estimate of $128.00. Observing a 8.14% increase, the current average has risen from the previous average price target of $145.38.
Deciphering Analyst Ratings: An In-Depth Analysis
An...
Login or create a forever free account to read this news
Sign up/Log in